Document is current

Article History

Received: 17 October 2025

Revised: 3 March 2026

Accepted: 9 May 2026

First Online: 20 May 2026

Declarations

:

: P.J. has received research support from Boston Scientific, Cook Medical, Fractyl, Morphic Medical, and USGI Medical, has served as a consultant to Boston Scientific, Cook Medical, ERBE, Fractyl, Morphic Medical, Olympus, Spatz Medical, and USGI Medical, is a co-founder of Bariendo, and has received royalty from Endosim. F.S. has no conflict of interest. D.L. has stock options in GI Windows. P.R. has no conflict of interest. M.R. has received research support from Boston Scientific and Olympus, has served as a consultant to Boston Scientific, Cook Medical, FujiFilm, Olympus, Medtronic, Enterasense, GI Windows, and has stock options in Enterasense and GI Windows. C.T. has served as a consultant for Boston Scientific, Endoquest Robotics, Enterasense, Enterra Medical, EnVision Endoscopy, Fractyl, Fujifilm, USGI Medical, Medtronic/Covidien, Olympus/Spiration, Softac, USGI Medical, Xenter and Morphic Medical, has served as an advisory boards member for USGI Medical and Fractyl, has received research grant and support from USGI Medical, Boston Scientific, ERBE, Fractyl, FujiFilm, Olympus/Spiration, Endoquest Robotics, GIE Medical and Morphic Medical, has served as a general partners for Blueframe Healthcare, Puma and Bioventures MedTech Funds, has served as a founder for Bariendo, Enterasense, EnVision Endoscopy and GI Windows, holds ownership interest for GI Windows, Xenter, EnVision Endoscopy, Enterasense and Softac and has received royalty from Endosim. R.B. has no conflict of interest.